Case Reports
Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Report and Literature Review
November 2023 | Volume 22 | Issue 11 | Case Reports | e24 | Copyright © November 2023
Introduction: Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare and dangerous dermatologic emergency. It can have different presentations, especially in pat...
Read MoreUtility of Pulsed-Dye Laser in the Treatment of Recalcitrant Hailey-Hailey Disease
November 2023 | Volume 22 | Issue 11 | Case Reports | e1 | Copyright © November 2023
Juvenile Pemphigus Foliaceus in a Patient With Psoriasis Receiving Narrow-Band Ultraviolet-B: Successful Treatment With Rituximab
August 2023 | Volume 22 | Issue 8 | Case Reports | 830 | Copyright © August 2023
Pemphigus foliaceus is an autoimmune blistering disease of the skin that is not frequently associated with mucous membrane involvement. It is characterized by immunoglobulin G (IgG) antibodies ag...
Read MoreTalquetamab-Induced Grover's Disease
August 2023 | Volume 22 | Issue 8 | Case Reports | 828 | Copyright © August 2023
Kresch M, Guénin S, Mubasher A, et al. Talquetamab-induced Grover’s disease. J Drugs Dermatol. 2023;22(8):828-829. doi:10.36849/JDD.7170...
Read MoreVerrucous Psoriasis: Rare Variant and Novel Treatment
August 2023 | Volume 22 | Issue 8 | Case Reports | 826 | Copyright © August 2023
Xenopoulou D, Pochat C, Greco E. Verrucous psoriasis: rare variant and novel treatment. J Drugs Dermatol. 2023;22(8):826-827. doi:10.36849/JDD.C6874R1...
Read MoreLeukemia Cutis in Skin of Color
July 2023 | Volume 22 | Issue 7 | Case Reports | 687 | Copyright © July 2023
The various presentations of many dermatologic conditions among various skin types are slowly being elucidated throughout the recent years. These differences present as an issue as it leads to de...
Read MoreErythrodermic Bullous Pemphigoid in Skin of Color Treated With Dupilumab
July 2023 | Volume 22 | Issue 7 | Case Reports | 685 | Copyright © July 2023
Bullous pemphigoid (BP) is an autoimmune blistering disease that typically presents with pruritic, tense bullae in elderly patients.1 Several recognized presentations deviate from the ...
Read MorePlacement of High Dose Neurotoxins for Treatment-Resistant Rosacea
June 2023 | Volume 22 | Issue 6 | Case Reports | 605 | Copyright © June 2023
Rosacea is a chronic inflammatory skin condition characterized by facial flushing, erythema, telangiectasias, and papulopustular lesions. Treatment for rosacea includes limiting inciting factors ...
Read MoreEruptive Squamous Cell Carcinomas Following Treatment With Fludarabine and Discussion of Treatment
May 2023 | Volume 22 | Issue 5 | Case Reports | 509 | Copyright © May 2023
Shah M, Wald J, Hanke CW. Eruptive Squamous cell carcinomas following treatment with fludarabine and discussion of treatment. J Drugs Dermatol. 2023;22(5):509-510....
Read MoreDilute Intralesional 5-Fluorouracil for the Treatment of Squamous Cell Carcinomas and Keratoacanthomas: A Case Series
May 2023 | Volume 22 | Issue 5 | Case Reports | 507 | Copyright © May 2023
Background: Intralesional 5-fluorouracil (5-FU) is a promising, yet sparsely studied alternative to surgical treatment for nonmelanoma skin cancer (NMSC).1 Previous studies of in...
Read MoreOpen-Label Phase 2 Pilot Study of Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE)
April 2023 | Volume 22 | Issue 4 | Features | 425 | Copyright © April 2023
Citation: Alsukait S, Learned C, Rosmarin D. Open-label phase 2 pilot study of oral tofacitinib in adult subjects with Discoid Lupus Erythematosus (DLE). J Drugs Dermatol. 2023;22(4)...
Read MoreDermal Hypersensitivity Reaction to Semaglutide: Two Case Reports
April 2023 | Volume 22 | Issue 4 | Case Reports | 413 | Copyright © April 2023
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of antidiabetic agents that work by inducing insulin secretion and inhibiting release of glucagon in a glucose-dependent manner. They...
Read MoreBrodalumab: 4-Year US Pharmacovigilance Report
April 2023 | Volume 22 | Issue 4 | Features | 419 | Copyright © April 2023
Brodalumab is an interleukin-17 receptor A antagonist approved for the treatment of moderate-to-severe psoriasis in adults without response or with loss of response to other systemic therapies. B...
Read MoreGraham-Little-Piccardi-Lasseur Syndrome: A Case Report
February 2023 | Volume 22 | Issue 2 | Case Reports | 210 | Copyright © February 2023
Graham-Little Piccardi-Lasseur syndrome is a rare dermatosis that affects the hair follicles throughout the body and often presents with a progressive cicatricial alopecia of the scalp that is unrespo...
Read MoreAcute Onset Linear Lichen Planus Pigmentosus of the Forehead: A Case Series
January 2023 | Volume 22 | Issue 1 | Case Reports | 94 | Copyright © January 2023
Linear lichen planus pigmentosus (LPP) of the face is a rare variant of lichen planus, with only a few cases published in the literature.1 It is an inflammatory condition with unknown et...
Read MoreACGME Program Requirements for Surgical Specialties: How Do Dermatology and MSDO Stack Up?
January 2023 | Volume 22 | Issue 1 | Case Reports | 90 | Copyright © January 2023
Dermatology and micrographic surgery and dermatologic oncology (MSDO) are two areas of medicine where surgical procedures play an important role both in training and practice. We sought to determin...
Read MoreRefractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy
December 2022 | Volume 21 | Issue 12 | Case Reports | 1366 | Copyright © December 2022
Background: In the last several years, oral tofacitinib has become an increasingly utilized off-label treatment option for immune-mediated skin conditions such as alopecia areata (AA)...
Read MoreNovel Regimen of IL-17A Inhibitor Secukinumab for the Remission of Severe Hidradenitis Suppurativa: Case Report
December 2022 | Volume 21 | Issue 12 | Case Reports | 1358 | Copyright © December 2022
Hidradenitis suppurativa (HS) is a morbid, recurrent skin condition that presents a major challenge to clinical therapy. Investigation into the pathogenesis of HS has implicated local and systemic pro...
Read MoreA Case of Successful Management of Adult-Onset Linear IgA Bullous Disease With Sulfasalazine During the COVID-19 Pandemic
December 2022 | Volume 21 | Issue 12 | Case Reports | 1355 | Copyright © December 2022
Linear IgA bullous disease (LABD) is a rare, acquired, autoimmune, pruritic, and blistering skin condition. Dapsone is a first line treatment option, however, there are limited options if this fails, ...
Read MoreTreatment of Reactive Keratoacanthomas with Acitretin Following Multiple Excisions and Mohs Surgery for Recurrent Squamous Cell Carcinoma
December 2022 | Volume 21 | Issue 12 | Case Reports | 1353 | Copyright © December 2022
Surgical intervention is seen as the gold standard in the treatment of Squamous cell carcinoma. Yet, in cases of recurrence, repeated surgical procedures may unwittingly foment the rise of reactive ke...
Read More